IL2 and tuberculosis: Taken together these findings indicate the decreased IL-2 to Rv1986 response prior to therapy correlates with increased susceptibility better than the IFN-γ response to CFP-10/ESAT-6; and that the partial but significant recovery of IL-2 to Rv1986, but unchanged IFN-γ response to CFP-10/ESAT-6 also correlates with the recognized decrease in tuberculosis susceptibility that is conferred by cART.